These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32951521)

  • 21. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin.
    Thorevska N; Amoateng-Adjepong Y; Sabahi R; Schiopescu I; Salloum A; Muralidharan V; Manthous CA
    Chest; 2004 Mar; 125(3):856-63. PubMed ID: 15006942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.
    Lin H; Faraklas I; Saffle J; Cochran A
    J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
    Nicklaus MD; Ludwig SL; Kettle JK
    J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C; Omran H
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study.
    Cohoon KP; De Sanctis Y; Haskell L; McBane RD; Spiro TE
    J Thromb Haemost; 2018 Jul; 16(7):1278-1287. PubMed ID: 29753308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.
    Gerber DE; Segal JB; Levy MY; Kane J; Jones RJ; Streiff MB
    Blood; 2008 Aug; 112(3):504-10. PubMed ID: 18480425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis.
    Bushwitz J; LeClaire A; He J; Mozingo D
    J Burn Care Res; 2011; 32(6):578-82. PubMed ID: 21841495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3).
    Eriksson BI; Agnelli G; Gallus AS; Lassen MR; Prins MH; Renfurm RW; Kashiwa M; Turpie AG
    Thromb Haemost; 2014 Feb; 111(2):213-25. PubMed ID: 24136153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies.
    Lepercq J; Conard J; Borel-Derlon A; Darmon JY; Boudignat O; Francoual C; Priollet P; Cohen C; Yvelin N; Schved JF; Tournaire M; Borg JY
    BJOG; 2001 Nov; 108(11):1134-40. PubMed ID: 11762651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an enoxaparin dosing calculator using burn size and weight.
    Faraklas I; Ghanem M; Brown A; Cochran A
    J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial.
    Connelly CR; Van PY; Hart KD; Louis SG; Fair KA; Erickson AS; Rick EA; Simeon EC; Bulger EM; Arbabi S; Holcomb JB; Moore LJ; Schreiber MA
    JAMA Surg; 2016 Oct; 151(10):e162069. PubMed ID: 27487253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation.
    Gonsalves A; Carrier M; Wells PS; McDiarmid SA; Huebsch LB; Allan DS
    J Thromb Haemost; 2008 Sep; 6(9):1468-73. PubMed ID: 18627443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients.
    Kramme K; Sarraf P; Munene G
    J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
    Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
    Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.
    Martinelli I; Lensing AW; Middeldorp S; Levi M; Beyer-Westendorf J; van Bellen B; Bounameaux H; Brighton TA; Cohen AT; Trajanovic M; Gebel M; Lam P; Wells PS; Prins MH
    Blood; 2016 Mar; 127(11):1417-25. PubMed ID: 26696010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.